ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

INKT MiNK Therapeutics Inc

0.932401
-0.0083 (-0.88%)
최종 업데이트: 00:27:47
15분 지연
기업명 주식 심볼 시장 주식 타입
MiNK Therapeutics Inc INKT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0083 -0.88% 0.932401 00:27:47
개장가 저가 고가 종가 전일 종가
0.9405 0.93 0.9774 0.9407
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202420:30GLOBEMiNK to Provide Corporate Update and First Quarter 2024..
09/04/202401:00GLOBEMiNK Therapeutics Announces Promising Preclinical Activity..
21/03/202420:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
21/03/202420:00GLOBEMiNK Reports Fourth Quarter and Year-End 2023 Results
07/03/202421:30GLOBEMiNK to Provide Corporate Update and Fourth Quarter & Full..
06/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:05EDGAR2Form 8-K - Current report
14/02/202422:00EDGAR2Form 8-K - Current report
14/02/202422:00GLOBEFirst Refractory Gastric Cancer Patient Dosed in Phase 2..
06/02/202422:00GLOBEMiNK Therapeutics' AgenT-797 Shows Promising Results in the..
30/01/202422:00GLOBEMiNK’s AgenT-797 Offers New Hope in Overcoming ICI..
19/01/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202321:30GLOBEImmunoScape and MiNK Therapeutics Collaborate to Accelerate..
06/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202321:00EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEMiNK Therapeutics Reports Third Quarter 2023 Results
04/11/202301:00GLOBEMiNK Therapeutics Presents Clinical Activity and Long-Term..
30/10/202321:00GLOBEMiNK to Provide Third Quarter 2023 Financial Report and..
18/10/202305:15EDGAR2Form 8-K - Current report
27/09/202322:05GLOBEMiNK Therapeutics To Present Data Update From Allogeneic..
07/09/202306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202321:30GLOBEMiNK Therapeutics to Participate in September Investor..
11/08/202320:44EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/08/202320:30EDGAR2Form 8-K - Current report
10/08/202320:30GLOBEMiNK Therapeutics Reports Second Quarter 2023 Results
10/08/202320:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/07/202321:30GLOBEMiNK to Provide Second Quarter 2023 Financial Report and..
05/06/202320:30GLOBEMiNK Therapeutics Announces Virtual Annual Shareholders..
22/05/202321:30GLOBEMiNK Presents Clinical Data on Allogeneic iNKT Cells..
18/05/202321:30GLOBEMiNK's Novel FAP-CAR-iNKT Presented at ASGCT
11/05/202321:00GLOBEMiNK Therapeutics Reports Corporate Update and First Quarter..

최근 히스토리

Delayed Upgrade Clock